Home Infusion Therapy Market To Reach $61.72 Billion By 2030

Home Infusion Therapy Market Growth & Trends

The global home infusion therapy market size is expected to reach USD 61.72 billion by 2030, registering a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

 Request a free sample copy or view report summary: Home Infusion Therapy Market Report

Home Infusion Therapy Market Report Highlights

• The services segment dominated the home infusion therapy market, accounting for 72.4% of the global revenue in 2024.

• Anti-infectives dominated the market with the largest revenue share in 2024. This is attributed to the considerable number of procedures performed for the administration of antifungal and antibiotic drugs.

• North America dominated the market with a revenue share of 56.6% in 2024. This can be attributed to the increasing R&D in the region and the rising adoption of new technology in infusion pumps.

• The U.S. home infusion therapy market is expected to grow over the forecast period, primarily driven by the increasing prevalence of chronic diseases and the cost-effectiveness of home-based care.

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of type, application, and region:

Home Infusion Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)

• Product

  • Infusion Pumps

    • Elastomeric

    • Electromechanical

    • Gravity

    • Others

  • Intravenous Sets

  • IV Cannulas

  • Needleless Connectors

• Services

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)

• Anti-Infective

• Endocrinology

  • Diabetes

  • Others

• Hydration Therapy

  • Athlete

  • Others

• Chemotherapy

• Enteral Nutrition

• Parenteral Nutrition

• Specialty Pharmaceuticals

• Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Netherlands

  • Belgium

  • Switzerland

  • Russia

  • Sweden

  • Rest of Europe

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Malaysia

  • Singapore

  • Thailand

  • Philippines

  • Rest of Asia Pacific

• Latin America

  • Brazil

  • Argentina

  • Colombia

  • Chile

  • Rest of Latin America

• Middle East & Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Israel

  • Egypt

  • Rest of Middle East & Africa (MEA)

List of Key Players of Home Infusion Therapy Market

• Baxter

• B. Braun SE

• BD

• Fresenius Kabi AG

• ICU Medical, Inc.

• Terumo Corporation

• JMS Co. Ltd.

• Option Care Health, Inc.

• CareCentrix, Inc.

• Coram LLC.

• PharMerica Corporation

• Moog Inc.

• Amedisys, Inc.